Financials

  • Market Capitalization 47.4 B
  • Employee 883
  • Founded 2014
  • CEO N/A
  • Website www.revmed.com
  • Headquarter Delaware, United States
  • FIGI BBG00829F4P8
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-13.39
ratio cours/chiffre d'affaires

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
259
ARGX
argenx SE - American Depositary Shares
1058.90 USD+1.13%+2.43%+21.11%+50.13%65.53 B USD
290
MRNA
Moderna, Inc. - Common Stock
142.77 USD-4.60%+7.75%+159.39%+488.50%57.00 B USD
444
ALNY
Alnylam Pharmaceuticals, Inc. - Common Stock
236.56 USD-1.02%+3.36%-17.82%-47.73%31.65 B USD
485
RPRX
Royalty Pharma plc - Class A Ordinary Shares
61.92 USD+0.19%+2.30%+3.36%+66.18%27.65 B USD

Nouvelles